Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending October 13, 2004. The report details changes in directors' interests in the company's Ordinary Shares and transactions involving the GlaxoSmithKline Employee Trust (GSK Trust).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on equity transactions and share prices related to employee incentive plans.
- Share Price (Oct 11, 2004): GBP 11.70 per Ordinary Share (ShareReward Plan).
- Share Price (Oct 8, 2004): GBP 11.74 per Ordinary Share (GSK Trust sales).
Material Changes
The filing reports specific transactions regarding directors' interests and trust distributions during October 2004:
- Director Acquisition: Mr. J D Coombe acquired 20 Ordinary Shares (10 personal contribution, 10 company match) under the ShareReward Plan on October 11, 2004.
- Trust Transfers: The GSK Trust transferred 7,522 shares to participants in the Performance Share Plan and Mid Term Incentive Plan, and 1,036 shares to participants in the Employee Share Option Plan 1991.
- Trust Sales: The GSK Trust sold 2,918 shares on behalf of plan participants.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is a statutory disclosure of director shareholdings and trust activities.
Investor Verification Points
- Verify the total number of shares held by Director Mr. J D Coombe following the October 11, 2004 acquisition.
- Confirm the impact of the GSK Trust sales and transfers on the company's outstanding share count.
- Review the terms of the ShareReward Plan, Performance Share Plan, and Employee Share Option Plan 1991 to understand vesting conditions.